3-Chloro-2,4,5-trifluoro-6-nitrobenzoic acid, 97%, 500mg

DBD-NCS [=4-(N,N-Dimethylaminosulfonyl)-7-isothiocyanato-2,1,3-benzoxadiazole] [for HPLC Labeling and Edman Degradation]100mg

Di-tert-butyl hydrazodiformate, 98.0%, 500g

Ethyl 6-bromo-2,2-dimethylhexanoate, 98%, 1g

N,2,6-trimethoxy-N-methylbenzamide, 95.0%, 2g

4-(4-(1,2,2-Triphenylvinyl)phenyl)pyridine, 98%, 250mg

1-(6-Bromo-1h-indol-3-yl)ethan-1-one, 95%, 5g

Spatole doppie forma micro rettangolare, 185 mm, 1 Pezzo

4,6-Dichloro-5-nitropicolinic acid, 98%, 5g

3-((2-Ethylhexyl)oxy)propane-1,2-diol, 97%, 5g

6-Bromo-2-chloroquinoline-4-carboxylic acid, 95%, 500mg

1-methyl-3-phenyl-1H-1,2,4-triazol-5-amine hydrochloride hydrate, 95.0%, 1g

4-Aminobutyric acid methyl ester, hydrochloride, 97.00%, 5g